Fabienne Cotte

Fabienne Cotte

Auto-generated profile, based on publicly available information

Fabienne Cotte

Ada Health GmbH, Berlin, Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2022 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
FCFabienne Cotte
Fabienne Cotte
TMTobias Mueller
Tobias Mueller
SGStephen Gilbert
Stephen Gilbert
BBBibiana Blümke
Bibiana Blümke
JMJan Multmeier
Jan Multmeier
AJAndreas Jerrentrup
Andreas Jerrentrup
Background: Increasing use of emergency departments (EDs) by patients with low urgency, combined with limited availability of medical staff, results in extended waiting times and delayed care. Technological approaches could possibly increase efficiency by providing urgency advice and symptom assessments. Objective: The purpose of this study is to evaluate the safety of urgency advice provided by a symptom assessment app, Ada, in an ED. Methods: The study was conducted at the interdisciplinary ED of Marburg University Hospital, with data collection performed between August 2019 and March 2020. This study had a single-center cross-sectional prospective observational design and included 378 patients. The app’s urgency recommendation was compared with an established triage concept (Manchester Triage System [MTS]), including patients from the lower 3 MTS categories only. For all patients who were undertriaged, an expert physician panel assessed the case to detect potential avoidable hazardous situations (AHSs). Results: Of 378 participants, 344 (91%) were triaged the same or more conservatively and 34 (8.9%) were undertriaged by the app. Of the 378 patients, 14 (3.7%) had received safe advice determined by the expert panel and 20 (5.3%) were considered to be potential AHS. Therefore, the assessment could be considered safe in 94.7% (358/378) of the patients when compared with the MTS assessment. From the 3 lowest MTS categories, 43.4% (164/378) of patients were not considered as emergency cases by the app, but could have been safely treated by a general practitioner or would not have required a physician consultation at all. Conclusions: The app provided urgency advice after patient self-triage that has a high rate of safety, a rate of undertriage, and a rate of triage with potential to be an AHS, equivalent to telephone triage by health care professionals while still being more conservative than direct ED triage. A large proportion of patients in the ED were not considered as emergency cases, which could possibly relieve ED burden if used at home. Further research should be conducted in the at-home setting to evaluate this hypothesis. Trial Registration: German Clinical Trial Registration DRKS00024909; https://www.drks.de/drks_web/navigate.do? navigationId=trial.HTML&TRIAL_ID=DRKS00024909

7 February 2022 in JMIR Formative Research
Verified
Journal Article
Open access
JSJustus Scheder-Bieschin
Justus Scheder-Bieschin
BBBibiana Blümke
Bibiana Blümke
EBErwin de Buijzer
Erwin de Buijzer
FCFabienne Cotte
Fabienne Cotte
FEFabian Echterdiek
Fabian Echterdiek
SGStephen Gilbert
Stephen Gilbert
Background: Establishing rapport and empathy between patients and their health care provider is important but challenging in the context of a busy and crowded emergency department (ED). Objective: We explore the hypotheses that rapport building, documentation, and time efficiency might be improved in the ED by providing patients a digital tool that uses Bayesian reasoning–based techniques to gather relevant symptoms and history for handover to clinicians. Methods: A 2-phase pilot evaluation was carried out in the ED of a German tertiary referral and major trauma hospital that treats an average of 120 patients daily. Phase 1 observations guided iterative improvement of the digital tool, which was then further evaluated in phase 2. All patients who were willing and able to provide consent were invited to participate, excluding those with severe injury or illness requiring immediate treatment, with traumatic injury, incapable of completing a health assessment, and aged <18 years. Over an 18-day period with 1699 patients presenting to the ED, 815 (47.96%) were eligible based on triage level. With available recruitment staff, 135 were approached, of whom 81 (60%) were included in the study. In a mixed methods evaluation, patients entered information into the tool, accessed by clinicians through a dashboard. All users completed evaluation Likert-scale questionnaires rating the tool’s performance. The feasibility of a larger trial was evaluated through rates of recruitment and questionnaire completion. Results: Respondents strongly endorsed the tool for facilitating conversation (61/81, 75% of patients, 57/78, 73% of physician ratings, and 10/10, 100% of nurse ratings). Most nurses judged the tool as potentially time saving, whereas most physicians only agreed for a subset of medical specialties (eg, surgery). Patients reported high usability and understood the tool’s questions. The tool was recommended by most patients (63/81, 78%), in 53% (41/77) of physician ratings, and in 76% (61/80) of nurse ratings. Questionnaire completion rates were 100% (81/81) by patients and 96% (78/81 enrolled patients) by physicians. Conclusions: This pilot confirmed that a larger study in the setting would be feasible. The tool has clear potential to improve patient–health care provider interaction and could also contribute to ED efficiency savings. Future research and development will extend the range of patients for whom the history-taking tool has clinical utility. Trial Registration: German Clinical Trials Register DRKS00024115; https://drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00024115

20 December 2023 in Journal of Medical Internet Research
Verified
Journal Article
Open access
CWCindy Welzel
Cindy Welzel
FCFabienne Cotte
Fabienne Cotte
MWMagdalena K. Wekenborg
Magdalena K. Wekenborg
BVBaptiste Vasey
Baptiste Vasey
PMPeter McCulloch
Peter McCulloch
SGStephen Gilbert
Stephen Gilbert
Digital health tools, platforms, and artificial intelligence– or machine learning–based clinical decision support systems are increasingly part of health delivery approaches, with an ever-greater degree of system interaction. Critical to the successful deployment of these tools is their functional integration into existing clinical routines and workflows. This depends on system interoperability and on intuitive and safe user interface design. The importance of minimizing emergent workflow stress through human factors research and purposeful design for integration cannot be overstated. Usability of tools in practice is as important as algorithm quality. Regulatory and health technology assessment frameworks recognize the importance of these factors to a certain extent, but their focus remains mainly on the individual product rather than on emergent system and workflow effects. The measurement of performance and user experience has so far been performed in ad hoc, nonstandardized ways by individual actors using their own evaluation approaches. We propose that a standard framework for system-level and holistic evaluation could be built into interacting digital systems to enable systematic and standardized system-wide, multiproduct, postmarket surveillance and technology assessment. Such a system could be made available to developers through regulatory or assessment bodies as an application programming interface and could be a requirement for digital tool certification, just as interoperability is. This would enable health systems and tool developers to collect system-level data directly from real device use cases, enabling the controlled and safe delivery of systematic quality assessment or improvement studies suitable for the complexity and interconnectedness of clinical workflows using developing digital health technologies.

7 October 2023 in Mayo Clinic Proceedings: Digital Health
Verified
Journal Article
Open access
SBStefanie Brückner
Stefanie Brückner
Toralf KirstenToralf Kirsten
Toralf Kirsten
Peter SchwarzPeter Schwarz
Peter Schwarz
FCFabienne Cotte
Fabienne Cotte
MTMichael Tsesis
Michael Tsesis
SGStephen Gilbert
Stephen Gilbert
The rise of health and wellness applications has led to a new category of citizen-generated health data, which are collected through sensors and user inputs. As more parameters are measured over longer time periods, these data will gradually become more important for disease prediction, care, and research than classical clinic-generated health data. Policymakers now recognize the potential of both data types in initiatives such as the European Health Data Space, which aims to enable data sharing for patient care and research at scale. Although it could be argued that clinic-generated data come from public-funded health systems and should therefore be sharable, after depersonalization, for public service, this argument extends poorly to data from wearables and applications. We propose a new approach for standardized health consent, both broad and dynamic, to overcome consent fatigue and engage citizens in data sharing.

28 August 2025 in JMIR AI
Verified
Journal Article
Open access
APAnne Pankow
Anne Pankow
NMNico Meißner-Bendzko
Nico Meißner-Bendzko
JKJessica Kaufeld
Jessica Kaufeld
LFLaura Fouquette
Laura Fouquette
FCFabienne Cotte
Fabienne Cotte
AWAnnette Doris Wagner
Annette Doris Wagner
Background: Rare diseases, which affect millions of people worldwide, pose a major challenge, as it often takes years before an accurate diagnosis can be made. This delay results in substantial burdens for patients and health care systems, as misdiagnoses lead to inadequate treatment and increased costs. Artificial intelligence (AI)–powered symptom checkers (SCs) present an opportunity to flag rare diseases earlier in the diagnostic work-up. However, these tools are primarily based on published literature, which often contains incomplete data on rare diseases, resulting in compromised diagnostic accuracy. Integrating expert interview insights into SC models may enhance their performance, ensuring that rare diseases are considered sooner and diagnosed more accurately. Objective: The objectives of our study were to incorporate expert interview vignettes into AI-powered SCs, in addition to a traditional literature review, and to evaluate whether this novel approach improves diagnostic accuracy and user satisfaction for rare diseases, focusing on Fabry disease. Methods: This mixed methods prospective pilot study was conducted at Hannover Medical School, Germany. In the first phase, guided interviews were conducted with medical experts specialized in Fabry disease to create clinical vignettes that enriched the AI SC’s Fabry disease model. In the second phase, adult patients with a confirmed diagnosis of Fabry disease used both the original and optimized SC versions in a randomized order. The versions, containing either the original or the optimized Fabry disease model, were evaluated based on diagnostic accuracy and user satisfaction, which were assessed through questionnaires. Results: Three medical experts with extensive experience in lysosomal storage disorder Fabry disease contributed to the creation of 5 clinical vignettes, which were integrated into the AI-powered SC. The study compared the original and optimized SC versions in 6 patients with Fabry disease. The optimized version improved diagnostic accuracy, with Fabry disease identified as the top suggestion in 33% (2/6) of cases, compared to 17% (1/6) with the original model. Additionally, overall user satisfaction was higher for the optimized version, with participants rating it more favorably in terms of symptom coverage and completeness. Conclusions: This study demonstrates that integrating expert-derived clinical vignettes into AI-powered SCs can improve diagnostic accuracy and user satisfaction, particularly for rare diseases. The optimized SC version, which incorporated these vignettes, showed improved performance in identifying Fabry disease as a top diagnostic suggestion and received higher user satisfaction ratings compared to the original version. To fully realize the potential of this approach, it is crucial to include vignettes representing atypical presentations and to conduct larger-scale studies to validate these findings.

16 June 2026 in Nature Health
Verified
Journal Article
Open access
MSMarcel Schmude
Marcel Schmude
SGStephen Gilbert
Stephen Gilbert
CLCaroline Moor Larsson
Caroline Moor Larsson
NGNoxolo Gqada
Noxolo Gqada
KLKris Lemon
Kris Lemon
FCFabienne Cotte
Fabienne Cotte
High maternal mortality rates persist as a critical challenge in low-resource settings. Here, in this prospective, observational mixed-methods study, we evaluated a Diagnostic Decision Support System integrated into MomConnect, South Africa’s government-led WhatsApp-based maternal health platform. Between May and June 2023, 968 pregnant women and mothers were enrolled, of whom 86.3% faced multiple barriers to care. Behaviour was assessed via platform surveys and phone interviews at 1-week follow-up. A physician panel rated Diagnostic Decision Support System advice safe in 98.4% (181/184; P < 0.001) of cases. After use, 44.6% (266/596) changed care-seeking intentions, and uncertainty dropped from 17.3% to 6.0%. By follow-up, 43.0% (337/785) had sought care, up from 17.0% initially. Safe behaviours increased by 18.1% ( P = 0.001) and appropriate behaviour by 10.5% ( P = 0.053). Half of those receiving treatment had not initially planned to seek care. Integrating clinical artificial intelligence into a government health platform was associated with safe advice and improved health-seeking behaviour. ClinicalTrials.gov: NCT06790069; funded by the Rockefeller Foundation.